Anti-Iron-hydroxamate ABC transporter substrate-bin Nanobody (VHH), Recombinant, Purified

Anti-Iron-hydroxamate ABC transporter substrate-bin Nanobody (VHH), Recombinant, Purified

Catalog #: EG-NB-9ULP
$425.00
View Cart
3D Structure — Nanobody–Epitope Complex
Loading 3D structure…
anti-Iron-hydroxamate ABC transporter substrate-bin nanobody complex
PDB 9ULP
nanobody (VHH)   antigen   epitope (27)
Drag to rotate · scroll to zoom

Interactive model of the VHH bound to its structural epitope on Iron-hydroxamate ABC transporter substrate-bin (from experimental complex PDB 9ULP). Nanobody in blue, epitope contact residues in red. For research visualization.

Product Description
Product NameAnti-Iron-hydroxamate ABC transporter substrate-bin Nanobody (VHH), Recombinant, Purified
DescriptionA purified, engineered single-domain antibody (VHH / nanobody) against Iron-hydroxamate ABC transporter substrate-bin, for research applications including detection, capture and imaging.
Target / SpecificityIron-hydroxamate ABC transporter substrate-bin
SequenceThis nanobody is an engineered variant based on PDB 9ULP, with higher affinity and stability than the original published sequence.
FormatPurified recombinant single-domain antibody (VHH / nanobody), carrier-free
Tag & ExpressionC-terminal 6×His tag; secreted from HEK293 cells and purified by one-step IMAC from the culture medium.
Molecular Weight~14 kDa (single VHH domain + His6; ~1/10 the size of a conventional IgG)
Purity>90% by SDS-PAGE
Quantity100 µg
FormulationPBS with 50% glycerol (carrier-free); 0.02% sodium azide
ApplicationsELISA, Western blot (WB), immunofluorescence (IF), immunoprecipitation (IP), affinity capture
Structural EpitopeEpitope mapped from the experimental VHH–antigen complex (PDB 9ULP); 27 antigen contact residues within 5 Å. An interactive 3D complex model is shown on this page.
StorageStore at -20°C; avoid repeated freeze-thaw. Stable 1 year.
AdvantagesNanobodies are the smallest functional antibody fragments: exceptional thermal and chemical stability, single-domain, high-yield recombinant production, and access to cryptic epitopes and dense tissue that conventional antibodies cannot reach.
Product Documents
DatasheetEG-NB-9ULP Product Datasheet
Download PDF
Related Products